Suppr超能文献

母亲患有家族性低钙血症性高钙血症 1 型(FHH1)时,其后代发生新生儿低钙血症性惊厥。

Neonatal Hypocalcemic Seizures in Offspring of a Mother With Familial Hypocalciuric Hypercalcemia Type 1 (FHH1).

机构信息

Department of Paediatric Endocrinology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.

Academic Endocrine Unit, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.

出版信息

J Clin Endocrinol Metab. 2020 May 1;105(5):1393-400. doi: 10.1210/clinem/dgaa111.

Abstract

CONTEXT

Familial hypocalciuric hypercalcemia type 1 (FHH1) is caused by loss-of-function mutations of the calcium-sensing receptor (CaSR) and is considered a benign condition associated with mild-to-moderate hypercalcemia. However, the children of parents with FHH1 can develop a variety of disorders of calcium homeostasis in infancy.

OBJECTIVE

The objective of this work is to characterize the range of calcitropic phenotypes in the children of a mother with FHH1.

METHODS

A 3-generation FHH kindred was assessed by clinical, biochemical, and mutational analysis following informed consent.

RESULTS

The FHH kindred comprised a hypercalcemic man and his daughter who had hypercalcemia and hypocalciuria, and her 4 children, 2 of whom had asymptomatic hypercalcemia, 1 was normocalcemic, and 1 suffered from transient neonatal hypocalcemia and seizures. The hypocalcemic infant had a serum calcium of 1.57 mmol/L (6.28 mg/dL); normal, 2.0 to 2.8 mmol/L (8.0-11.2 mg/dL) and parathyroid hormone of 2.2 pmol/L; normal 1.0 to 9.3 pmol/L, and required treatment with intravenous calcium gluconate infusions. A novel heterozygous p.Ser448Pro CaSR variant was identified in the hypercalcemic individuals, but not the children with hypocalcemia or normocalcemia. Three-dimensional modeling predicted the p.Ser448Pro variant to disrupt a hydrogen bond interaction within the CaSR extracellular domain. The variant Pro448 CaSR, when expressed in HEK293 cells, significantly impaired CaSR-mediated intracellular calcium mobilization and mitogen-activated protein kinase responses following stimulation with extracellular calcium, thereby demonstrating it to represent a loss-of-function mutation.

CONCLUSIONS

Thus, children of a mother with FHH1 can develop hypercalcemia or transient neonatal hypocalcemia, depending on the underlying inherited CaSR mutation, and require investigations for serum calcium and CaSR mutations in early childhood.

摘要

背景

家族性低钙血症性高钙血症 1 型(FHH1)是由钙敏感受体(CaSR)的功能丧失突变引起的,被认为是一种与轻度至中度高钙血症相关的良性疾病。然而,FHH1 父母的孩子在婴儿期可能会出现多种钙稳态紊乱。

目的

本研究旨在描述 FHH1 母亲的孩子中钙调节表型的范围。

方法

在知情同意后,通过临床、生化和突变分析评估了一个 3 代 FHH 家族。

结果

该 FHH 家族包括一名高钙血症男性及其女儿,他们均患有高钙血症和低钙尿症,其 4 名子女中,2 名无症状高钙血症,1 名血钙正常,1 名患有短暂性新生儿低钙血症和癫痫发作。低钙血症婴儿的血清钙为 1.57mmol/L(6.28mg/dL);正常值为 2.0-2.8mmol/L(8.0-11.2mg/dL),甲状旁腺激素为 2.2pmol/L;正常值为 1.0-9.3pmol/L,需要静脉输注葡萄糖酸钙治疗。在高钙血症个体中发现了一种新的杂合 p.Ser448Pro CaSR 变体,但在低钙血症或血钙正常的儿童中未发现。三维建模预测 p.Ser448Pro 变体破坏了 CaSR 细胞外域内的氢键相互作用。当表达在 HEK293 细胞中时,变体 Pro448 CaSR 显著损害了 CaSR 介导的细胞内钙动员和丝裂原活化蛋白激酶反应,这表明它代表了一种功能丧失突变。

结论

因此,FHH1 母亲的孩子可能会出现高钙血症或短暂性新生儿低钙血症,具体取决于潜在的遗传性 CaSR 突变,并需要在幼儿期进行血清钙和 CaSR 突变的调查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b97a/7096312/b02991b368fc/dgaa111f0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验